GMDS
Basic information
Region (hg38): 6:1623806-2245605
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GMDS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 12 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 1 | 0 |
Variants in GMDS
This is a list of pathogenic ClinVar variants found in the GMDS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-1624190-C-T | not specified | Uncertain significance (Nov 06, 2023) | ||
6-1624201-C-T | not specified | Uncertain significance (Jan 17, 2024) | ||
6-1726451-T-C | not specified | Uncertain significance (Jun 17, 2024) | ||
6-1742484-T-C | not specified | Uncertain significance (Mar 07, 2023) | ||
6-1742554-C-T | Likely benign (Dec 01, 2022) | |||
6-1742555-G-A | not specified | Uncertain significance (May 27, 2022) | ||
6-1930219-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
6-1959956-T-C | not specified | Uncertain significance (Feb 16, 2023) | ||
6-1960870-C-T | not specified | Uncertain significance (Mar 29, 2024) | ||
6-1960923-A-G | not specified | Uncertain significance (Mar 14, 2023) | ||
6-1960938-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
6-1960950-G-A | not specified | Uncertain significance (Aug 15, 2023) | ||
6-2117477-A-G | not specified | Uncertain significance (Sep 20, 2023) | ||
6-2117538-G-A | not specified | Uncertain significance (Feb 02, 2022) | ||
6-2117541-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
6-2245374-C-T | not specified | Uncertain significance (Apr 01, 2024) | ||
6-2245397-G-A | not specified | Uncertain significance (Jan 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GMDS | protein_coding | protein_coding | ENST00000380815 | 11 | 621886 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.991 | 0.00868 | 125736 | 0 | 10 | 125746 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.82 | 140 | 215 | 0.651 | 0.0000120 | 2418 |
Missense in Polyphen | 57 | 107.6 | 0.52973 | 1127 | ||
Synonymous | 0.963 | 73 | 84.2 | 0.867 | 0.00000509 | 702 |
Loss of Function | 4.06 | 2 | 23.0 | 0.0868 | 0.00000131 | 261 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000121 | 0.000120 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the conversion of GDP-D-mannose to GDP-4- dehydro-6-deoxy-D-mannose.;
- Pathway
- Fructose and mannose metabolism - Homo sapiens (human);Amino sugar and nucleotide sugar metabolism - Homo sapiens (human);Fructose intolerance, hereditary;Fructose and Mannose Degradation;Fructosuria;Fructose Mannose metabolism;Post-translational protein modification;Metabolism of proteins;GDP-fucose biosynthesis;Synthesis of substrates in N-glycan biosythesis;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;GDP-L-fucose biosynthesis I (from GDP-D-mannose)
(Consensus)
Recessive Scores
- pRec
- 0.229
Intolerance Scores
- loftool
- 0.198
- rvis_EVS
- -0.3
- rvis_percentile_EVS
- 32.62
Haploinsufficiency Scores
- pHI
- 0.203
- hipred
- Y
- hipred_score
- 0.774
- ghis
- 0.498
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.940
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gmds
- Phenotype
- hematopoietic system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; craniofacial phenotype;
Zebrafish Information Network
- Gene name
- gmds
- Affected structure
- secondary motor neuron
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- Notch signaling pathway;GDP-mannose metabolic process;'de novo' GDP-L-fucose biosynthetic process
- Cellular component
- cytoplasm;cytosol;extracellular exosome
- Molecular function
- protein binding;GDP-mannose 4,6-dehydratase activity;identical protein binding;NADP+ binding